Polymorphism in methylenetetrahydrofolate reductase, plasminogen activator inhibitor-1, and apolipoprotein E in hemodialysis patients

Polymorphism in methylenetetrahydrofolate reductase, plasminogen activator inhibitor-1, and apolipoprotein E in hemodialysis patients

The methylenetetrahydrofolate reductase (MTHFR) gene polymorphism, apolipoprotein E (apo s4) gene polymorphism and polymorphism of plasminogen activator inhibitor-1 (PAI-1) have been shown to be associated with end-stage renal disease (ESRD). To determine the prevalence of these mutations in Saudi p...

Full description

Bibliographic Details
Main Authors: Al-Muhanna Fahad, Al-Mueilo Samir, Al-Ali Amein, Larbi Emmanuel, Rubaish Abdullah, Abdulmohsen Mohammed, Al-Zahrani Alhussain, Al-Ateeq Suad
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2008-01-01
Series:Saudi Journal of Kidney Diseases and Transplantation
Subjects:
MTHFR
PAI-1
Apo c4
ESRD
Hemodialysis
Polymorphism
Online Access:http://www.sjkdt.org/article.asp?issn=1319-2442;year=2008;volume=19;issue=6;spage=937;epage=941;aulast=Al-Muhanna

Internet

http://www.sjkdt.org/article.asp?issn=1319-2442;year=2008;volume=19;issue=6;spage=937;epage=941;aulast=Al-Muhanna

Similar Items